Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationStem CellsAntineoplastic Combined Chemotherapy ProtocolsMelphalanMultiple MyelomaGraft vs Host DiseaseCombined Modality TherapyTreatment OutcomeBusulfanRemission InductionBone Marrow TransplantationMyeloablative AgonistsHematologic NeoplasmsCyclophosphamideDisease-Free SurvivalRecurrenceSalvage TherapyWhole-Body IrradiationEtoposideHodgkin DiseaseLymphoma, Non-HodgkinSurvival RateSurvival AnalysisHematopoietic Stem CellsCytarabineHematopoietic Stem Cell MobilizationCarmustineTransplantation ChimeraThiotepaGraft SurvivalBone Marrow PurgingRetrospective StudiesVincristineVidarabineTissue DonorsPrognosisLymphoma, Mantle-CellFollow-Up StudiesLeukemia, Myeloid, AcuteAntineoplastic Agents, AlkylatingEmbryonic Stem CellsTime FactorsAntigens, CD34Histocompatibility TestingDoxorubicinCord Blood Stem Cell TransplantationAmyloidosisGraft vs Tumor EffectAntibodies, Monoclonal, Murine-DerivedMesenchymal Stem Cell TransplantationImmunosuppressive AgentsAntineoplastic AgentsDexamethasoneBoronic AcidsLymphoma, FollicularMyelodysplastic SyndromesAdult Stem CellsNeoplasm, ResidualPyrazinesGraft vs Leukemia EffectLeukemiaHistocompatibilityGranulocyte Colony-Stimulating FactorThalidomideLymphoma, T-Cell, PeripheralAutograftsLymphomaLiver TransplantationIfosfamideLeukapheresisAntilymphocyte SerumInduction ChemotherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaPluripotent Stem CellsLeukemia, MyeloidPrednisoneLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHepatic Veno-Occlusive DiseaseAcute DiseaseCell DifferentiationPodophyllotoxinLymphocyte DepletionAntibodies, MonoclonalLymphoma, Large B-Cell, DiffuseStem Cell NicheCell TransplantationMaintenance ChemotherapyMesenchymal Stromal CellsLymphocyte TransfusionNeural Stem CellsHematologic DiseasesT-LymphocytesProspective StudiesCytomegalovirus InfectionsActuarial Analysis